US 12,226,607 B2
Radiopharmaceutical delivery system and use thereof for patient infusion
James A. Kaufman, Montreal (CA); Dominic Siewko, Kirkland (CA); and Indranil Nandi, Yardley, PA (US)
Assigned to Jubilant Draximage Inc., (CA)
Filed by Jubilant Draximage Inc., Montreal (CA)
Filed on Aug. 29, 2024, as Appl. No. 18/819,145.
Application 18/819,145 is a continuation of application No. 18/618,798, filed on Mar. 27, 2024, granted, now 12,102,789.
Claims priority of provisional application 63/492,628, filed on Mar. 28, 2023.
Prior Publication US 2024/0416031 A1, Dec. 19, 2024
Int. Cl. A61M 5/142 (2006.01); A61M 5/168 (2006.01); A61M 5/178 (2006.01); G16H 10/60 (2018.01); G16H 40/63 (2018.01)
CPC A61M 5/142 (2013.01) [A61M 5/16831 (2013.01); A61M 5/1785 (2013.01); G16H 10/60 (2018.01); G16H 40/63 (2018.01); A61M 2005/14208 (2013.01); A61M 2005/16863 (2013.01); A61M 2202/0007 (2013.01); A61M 2202/049 (2013.01); A61M 2205/10 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3327 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3379 (2013.01); A61M 2205/502 (2013.01); A61M 2205/584 (2013.01); A61M 2205/6009 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A radiopharmaceutical drug delivery system comprising;
a configurable dose transporter;
a separable radioactive dose transportation and containment module;
a shielding positioned around at least a portion of the radioactive dose transportation and containment module;
a disposable sealed fluid cartridge mountable within the configurable dose transporter; and
a theranostic informatics management system;
wherein the disposable sealed fluid cartridge comprises:
a) an adapter to secure a drug vial or syringe to the fluid cartridge;
b) one or more integrated fluid channels to allow bi-directional flow of fluids;
c) an integrated precision pump configured to control the flow of a customizable amount of a radioactive drug;
d) a coded patient port and a coded saline port, wherein the coded patient port and the coded saline port are configured to present differently a patient line and a saline line to a user;
e) an integral valve system to control flow of fluids through the integrated fluid channels; and
f) one or more guide features and mechanical interlocks that interact with one or more guide features and mechanical interlocks on the dose transportation and containment module when the fluid cartridge is mounted to the configurable dose transporter.